{"title": "Trend analysis of the COVID-19 pandemic in China and the rest of the world", "doi": "10.1101/2020.03.19.20037192", "citation_id": "2020.03.19.20037192v1", "date": "2020-03-23", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.19.20037192", "abstract": "<p>The recent epidemic of Coronavirus (COVID-19) that started in China has already\nbeen \"exported\" to more than 140 countries in all the continents, evolving in most\nof them by local spreading. In this contribution we analyze the trends of the cases\nreported in all the Chinese provinces, as well as in some countries that, until March\n15th, 2020, have more than 500 cases reported. Notably and differently from other\nepidemics, the provinces did not show an exponential phase. The data available at\nthe Johns Hopkins University site seem to fit well an algebraic sub-exponential\ngrowing behavior as was pointed out recently. All the provinces show a clear and\nconsistent pattern of slowing down with growing exponent going nearly zero, so it can\nbe said that the epidemic was contained in China. On the other side, the more recent\nspread in countries like, Italy, Iran, and Spain show a clear exponential growth, as\nwell as other European countries. Even more recently, US -which was one of\nthe first countries to have an individual infected outside China (Jan 21st, 2020)-\nseems to follow the same path. We calculate the exponential growth of the most\naffected countries, showing the evolution along time after the first local case. We\nidentify clearly different patterns in the analyzed data and we give interpretations\nand possible explanations for them. The analysis and conclusions of our study can\nhelp countries that, after importing some cases, are not yet in the local spreading\nphase, or have just started</p>", "twitter_description": "The recent epidemic of Coronavirus (COVID-19) that started in China has already been \"exported\" to more than 140 countries in all the continents, evolving in most of them by local spreading. In this contribution we analyze the trends of the cases reported in all the Chinese provinces, as well as in some countries that, until March 15th, 2020, have more than 500 cases reported. Notably and differently from other epidemics, the provinces did not show an exponential phase. The data available at the Johns Hopkins University site seem to fit well an algebraic sub-exponential growing behavior as was pointed out recently. All the provinces show a clear and consistent pattern of slowing down with growing exponent going nearly zero, so it can be said that the epidemic was contained in China. On the other side, the more recent spread in countries like, Italy, Iran, and Spain show a clear exponential growth, as well as other European countries. Even more recently, US -which was one of the first countries to have an individual infected outside China (Jan 21st, 2020)- seems to follow the same path. We calculate the exponential growth of the most affected countries, showing the evolution along time after the first local case. We identify clearly different patterns in the analyzed data and we give interpretations and possible explanations for them. The analysis and conclusions of our study can help countries that, after importing some cases, are not yet in the local spreading phase, or have just started\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nSG acknowledges CAPES for support, under fellowship \\#003/2019 - PROPG - PRINT/UFRGS\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nAll the data used in this study is available at the Data Repository by Center for Systems Science and Engineering of the Johns Hopkins University: https://github.com/CSSEGISandData/COVID-19/blob/master/csse\\_covid\\_19\\\\_data/csse\\_covid\\_19\\_time\\_series/time\\_series\\_19-covid-Confirmed.csv", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.19.20037192v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.19.20037192v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.19.20037192v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/23/2020.03.19.20037192.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.19.20037192v1", "access_rights": "restricted", "authors": ["Albertine Weber", "Flavio Iannelli", "Sebastian Goncalves"]}